Home

John D Morberg

CIK 1345964 · Chief Financial Officer · last filed 2024-01-22

John D Morberg is a Chief Financial Officer who has filed 21 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for LFCR, was dated Nov 20, 2024. Across all open-market trades the lifetime net is +$215.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $587.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$587.9K

Companies

2

Total Filings

21

Lifetime Open-Market Net

$215.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LFCR Chief Financial Officer 125,617 $4.68 $587.9K $0 2 2024-01-22
LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Chief Financial Officer 19,400 $8.76 $169.9K $215.6K 14 2022-08-15

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-11-20 LFCR Notice (144) −10,000 -$71.7K EDGAR
2024-11-12 LFCR Notice (144) −30,990 -$205.8K EDGAR
2024-10-31 LFCR Notice (144) −40,989 -$232.9K EDGAR
2024-10-07 LFCR Notice (144) −12,617 -$65.5K EDGAR
2024-09-20 LFCR Notice (144) −15,000 -$82.3K EDGAR
2024-01-22 LFCR Mixed +11,217 $0 EDGAR
2023-06-05 LFCR Grant (A) +95,000 $0 EDGAR
2022-08-15 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Grant (A) — $0 EDGAR
2022-07-18 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Grant (A) — $0 EDGAR
2021-07-28 LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.